Pharmaceutical Market
🇪🇺 EMAEMA news and analysis for pharmaceutical BD, investment, and market access
Unlock global pharmaceutical market insights. Stay ahead with critical data on drug development trends, market access, and competitive intelligence for investors and BD.
Showing 1–12 of 21 articles
Quick answer
NovaPharmaNews Pharmaceutical Market hub for EMA covers 21 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Maersk Europe Market Update June 2026: Key Changes for Pharma Supply Chains
MFN Drug Pricing Reshapes International Life Sciences Licensing Deals
EU Bolsters Trade Defenses Against Chinese Imports: A Pharmaceutical Market Analysis
SFEE Highlights Significant Delays in Greek Patient Access to New Medicines
FDA Approves Baxdrostat (Baxfendy) as First Aldosterone Synthase Inhibitor for Uncontrolled Hypertension
Rethinking QA/QC at The Future of Bio/Pharmaceutical Analysis 2026
Innovent Biologics and Pfizer's $10.5 Billion Cancer Drug Deal
Innovent Biologics Shares Surge 10% Following Pfizer Deal
Critical Medicines Act: Council and Parliament Reach Provisional Deal
CVS Restores Coverage for Eli Lilly's Obesity Medications
Critical Medicines Act Targets Europe's Medicines Shortages
AI Accelerates Novo Nordisk's Parkinson’s Cell Therapy
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.